Generate Biomedicines, Inc. (GENB)
14.34
+0.36
(+2.54%)
USD |
NASDAQ |
Oct 09, 16:00
14.34
0.00 (0.00%)
After-Hours: 20:00
Generate Biomedicines Market Cap : 1.840B for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.794B |
| October 07, 2026 | 1.741B |
| October 06, 2026 | 1.770B |
| October 05, 2026 | 1.784B |
| October 02, 2026 | 1.756B |
| October 01, 2026 | 1.770B |
| September 30, 2026 | 1.927B |
| September 29, 2026 | 1.978B |
| September 28, 2026 | 1.912B |
| September 25, 2026 | 1.943B |
| September 24, 2026 | 2.051B |
| September 23, 2026 | 2.119B |
| September 22, 2026 | 2.240B |
| September 21, 2026 | 2.229B |
| September 18, 2026 | 2.199B |
| September 17, 2026 | 2.196B |
| September 16, 2026 | 2.011B |
| September 15, 2026 | 2.077B |
| September 14, 2026 | 2.052B |
| September 11, 2026 | 2.016B |
| September 10, 2026 | 1.974B |
| September 09, 2026 | 1.991B |
| September 08, 2026 | 2.039B |
| September 04, 2026 | 2.102B |
| September 03, 2026 | 2.096B |
| Date | Value |
|---|---|
| September 02, 2026 | 2.088B |
| September 01, 2026 | 2.025B |
| August 31, 2026 | 1.959B |
| August 28, 2026 | 1.966B |
| August 27, 2026 | 2.023B |
| August 26, 2026 | 2.070B |
| August 25, 2026 | 2.614B |
| August 24, 2026 | 2.273B |
| August 21, 2026 | 2.068B |
| August 20, 2026 | 2.051B |
| August 19, 2026 | 2.177B |
| August 18, 2026 | 2.063B |
| August 17, 2026 | 2.013B |
| August 14, 2026 | 2.006B |
| August 13, 2026 | 1.928B |
| August 12, 2026 | 1.936B |
| August 11, 2026 | 1.830B |
| August 10, 2026 | 1.888B |
| August 07, 2026 | 1.841B |
| August 06, 2026 | 1.782B |
| August 05, 2026 | 1.859B |
| August 04, 2026 | 1.832B |
| August 03, 2026 | 1.838B |
| July 31, 2026 | 1.795B |
| July 30, 2026 | 1.799B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Twist Bioscience Corp. | 10.02B |
| Intellia Therapeutics, Inc. | 1.831B |
| Prime Medicine, Inc. | 722.05M |
| Beam Therapeutics, Inc. | 2.656B |
| Moderna, Inc. | 89.58B |
Market Cap Related Metrics
| PS Ratio | 35.60 |
| Price to Book Value | 4.035 |
| Price | 14.34 |
| Earnings Yield | -32.20% |